Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Bakuchiol cream is efficacious against acne in open-label trial

Feb. 9, 2011

AV-7909 improves survival of ciprofloxacin-treated guinea pigs exposed to B. anthracis

Feb. 9, 2011

AB-103 protects mice from SEB- and LPS-induced lethal shock

Feb. 9, 2011

Combination of 90Y-hPAM4 and gemcitabine shows promise in advanced pancreatic cancer

Feb. 8, 2011

Algenpantucel-L plus adjuvant therapy improves survival of patients with resected pancreatic cancer

Feb. 8, 2011

Apremilast reduces severity of psoriasis and improves quality of life

Feb. 8, 2011

Snapshots: Recent clinical trials of briakinumab in psoriasis

Feb. 8, 2011

SHELTER trial data reported on resminostat in sorafenib-resistant hepatocellular carcinoma

Feb. 7, 2011

Armed oncolytic virus OBP-702 active against osteosarcoma cells

Feb. 7, 2011

PCI-27483/gemcitabine combination is safe in advanced/metastatic pancreatic cancer

Feb. 7, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...